These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21756010)

  • 21. [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations].
    Drabik A; Graf C; Büscher G; Stock S
    Z Evid Fortbild Qual Gesundhwes; 2012; 106(9):649-55. PubMed ID: 23200208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The quality of chronic care in Germany].
    Fullerton B; Nolte E; Erler A
    Z Evid Fortbild Qual Gesundhwes; 2011; 105(8):554-62. PubMed ID: 22142877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887].
    Joos S; Rosemann T; Heiderhoff M; Wensing M; Ludt S; Gensichen J; Kaufmann-Kolle P; Szecsenyi J
    BMC Public Health; 2005 Oct; 5():99. PubMed ID: 16202151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.
    Sidorenkov G; Voorham J; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
    BMJ Qual Saf; 2013 Apr; 22(4):339-47. PubMed ID: 23386729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Improvements in type 2 diabetes care? Pooled analysis of survey data in southern Germany (KORA) from 1999-2008].
    Schunk M; Stark R; Reitmeir P; Rathmann W; Meisinger C; Holle R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Nov; 54(11):1187-96. PubMed ID: 22015791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Life prolonging of disease management programs in patients with type 2 diabetes is cost-effective.
    Drabik A; Büscher G; Sawicki PT; Thomas K; Graf C; Müller D; Stock S
    Diabetes Res Clin Pract; 2012 Feb; 95(2):194-200. PubMed ID: 22004943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal medicine resident training and provision of diabetes quality of care indicators.
    Devkota BP; Ansstas M; Scherrer JF; Salas J; Budhathoki C
    Can J Diabetes; 2015 Apr; 39(2):133-7. PubMed ID: 25499028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics, management and attainment of lipid target levels in diabetic and cardiac patients enrolled in Disease Management Program versus those in routine care: LUTZ registry.
    Bestehorn K; Jannowitz C; Karmann B; Pittrow D; Kirch W
    BMC Public Health; 2009 Aug; 9():280. PubMed ID: 19653899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [General practitioners' perspectives on the perceived effectiveness of the disease management programs for type 2 diabetes and coronary heart disease: Results of a focus group study].
    Pilic L; Molkentin K; Lehmann L; Herrmann A; Funke C; Müller BS; Bödecker AW; Redaèlli M; Wilm S
    Z Evid Fortbild Qual Gesundhwes; 2024 Apr; 185():45-53. PubMed ID: 38418359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Social disparities in Disease Management Programmes for coronary heart disease in Germany: a cross-classified multilevel analysis.
    Bozorgmehr K; Maier W; Brenner H; Saum KU; Stock C; Miksch A; Holleczek B; Szecsenyi J; Razum O
    J Epidemiol Community Health; 2015 Nov; 69(11):1091-101. PubMed ID: 26082518
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective enrollment in Disease Management Programs for coronary heart disease in Germany - An analysis based on cross-sectional survey and administrative claims data.
    Röttger J; Blümel M; Busse R
    BMC Health Serv Res; 2017 Apr; 17(1):246. PubMed ID: 28372554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physician compensation from salary and quality of diabetes care.
    Kim C; Steers WN; Herman WH; Mangione CM; Narayan KM; Ettner SL
    J Gen Intern Med; 2007 Apr; 22(4):448-52. PubMed ID: 17372791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of disease management programs in the health behavior of chronically ill patients.
    Cramm JM; Adams SA; Walters BH; Tsiachristas A; Bal R; Huijsman R; Rutten-Van Mölken MP; Nieboer AP
    Patient Educ Couns; 2014 Apr; 95(1):137-42. PubMed ID: 24462120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysing horizontal equity in enrolment in Disease Management Programmes for coronary heart disease in Germany 2008-2010.
    Bozorgmehr K; San Sebastian M; Brenner H; Razum O; Maier W; Saum KU; Holleczek B; Miksch A; Szecsenyi J
    Int J Equity Health; 2015 Mar; 14():28. PubMed ID: 25879523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploring Health System Responsiveness in Ambulatory Care and Disease Management and its Relation to Other Dimensions of Health System Performance (RAC) - Study Design and Methodology.
    Röttger J; Blümel M; Engel S; Grenz-Farenholtz B; Fuchs S; Linder R; Verheyen F; Busse R
    Int J Health Policy Manag; 2015 May; 4(7):431-7. PubMed ID: 26188807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selection effects may account for better outcomes of the German Disease Management Program for type 2 diabetes.
    Schäfer I; Küver C; Gedrose B; von Leitner EC; Treszl A; Wegscheider K; van den Bussche H; Kaduszkiewicz H
    BMC Health Serv Res; 2010 Dec; 10():351. PubMed ID: 21194442
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The methods within the evaluation of disease management programmes in control-group designs using the example of diabetes mellitus - a systematic literature review].
    Drabik A; Sawicki PT; Müller D; Passon A; Stock S
    Gesundheitswesen; 2012 Aug; 74(8-9):496-501. PubMed ID: 22454226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effectiveness of German disease management programs (DMPs) in patients with type 2 diabetes mellitus and coronary heart disease: results from an observational longitudinal study.
    Laxy M; Stark R; Meisinger C; Kirchberger I; Heier M; von Scheidt W; Holle R
    Diabetol Metab Syndr; 2015; 7():77. PubMed ID: 26388948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Nonfatal Stroke in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison Between Disease Management Programs and Standard Care.
    Wiefarn S; Heumann C; Rettelbach A; Kostev K
    J Diabetes Sci Technol; 2017 Jul; 11(4):808-813. PubMed ID: 28300432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The disease management program for type 2 diabetes in Germany enhances process quality of diabetes care - a follow-up survey of patient's experiences.
    Schäfer I; Küver C; Gedrose B; Hoffmann F; Russ-Thiel B; Brose HP; van den Bussche H; Kaduszkiewicz H
    BMC Health Serv Res; 2010 Mar; 10():55. PubMed ID: 20199685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.